Last reviewed · How we verify
Streptococcus Osteomyelitis
Approved treatments
- Cefaprin · Bristol-Myers Squibb
- Claforan · Sterimax
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Keflex · Shionogi
- Epocelin
- Rocephin · Generic (originally Roche)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Streptococcus Osteomyelitis patent landscape — cliff calendar, originator estates, attackable patents
- Streptococcus Osteomyelitis treatment landscape brief
- Streptococcus Osteomyelitis treatment updates RSS
Frequently asked questions about Streptococcus Osteomyelitis
What drugs treat Streptococcus Osteomyelitis?
Tracked treatments include Cefaprin, Claforan, Ceftriaxon, Keflex, Epocelin, Rocephin.
What is the treatment for Streptococcus Osteomyelitis?
Standard treatment for Streptococcus Osteomyelitis includes Cefaprin, Claforan, Ceftriaxon, Keflex, Epocelin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Streptococcus Osteomyelitis patent cliff · Streptococcus Osteomyelitis CI report
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Claforan · Sterimax
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Keflex · Shionogi
- Treatment: Epocelin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing